Managing localised cancer of the prostate

Yazar: Ritchie, A W S
Baskı/Yayın Bilgisi 1988

The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1.

Yazar: Ritchie, A W, James, K, Micklem, H S
Baskı/Yayın Bilgisi 1983

NATALI--a model for National Computer Databases in the investigation of new therapeutic techniques.

Yazar: Braithwaite, B D, Ritchie, A W, Earnshaw, J J
Baskı/Yayın Bilgisi 1995

Measures of mortality in prostatic cancer.

Yazar: Goodman, C. M., Ritchie, A. W., Chisholm, G. D.
Baskı/Yayın Bilgisi 1990

The influence of histological diagnosis on the postoperative complication rate following trans-urethral resection of prostate (TURP).

Yazar: Crow, P., Gilbert, H. W., Jones, D. J., Ritchie, A. W. S.
Baskı/Yayın Bilgisi 2002

Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies.

Yazar: Ritchie, A W, Oswald, I, Micklem, H S, Boyd, J E, Elton, R A, Jazwinska, E, James, K
Baskı/Yayın Bilgisi 1983

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

Yazar: Sydes, M R, Spears, M R, Mason, M D, Clarke, N W, Dearnaley, D P, de Bono, J S, Attard, G, Chowdhury, S, Cross, W, Gillessen, S, Malik, Z I, Jones, R, Parker, C C, Ritchie, A W S, Russell, J M, Millman, R, Matheson, D, Amos, C, Gilson, C, Birtle, A, Brock, S, Capaldi, L, Chakraborti, P, Choudhury, A, Evans, L, Ford, D, Gale, J, Gibbs, S, Gilbert, D C, Hughes, R, McLaren, D, Lester, J F, Nikapota, A, O’Sullivan, J, Parikh, O, Peedell, C, Protheroe, A, Rudman, S M, Shaffer, R, Sheehan, D, Simms, M, Srihari, N, Strebel, R, Sundar, S, Tolan, S, Tsang, D, Varughese, M, Wagstaff, J, Parmar, M K B, James, N D
Yayımlandı Ann Oncol (2018)

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

Yazar: James, N.D., de Bono, J.S., Spears, M.R., Clarke, N.W., Mason, M.D., Dearnaley, D.P., Ritchie, A.W.S., Amos, C.L., Gilson, C., Jones, R.J., Matheson, D., Millman, R., Attard, G., Chowdhury, S., Cross, W.R., Gillessen, S., Parker, C.C., Russell, J.M., Berthold, D.R., Brawley, C., Adab, F., Aung, S., Birtle, A.J., Bowen, J., Brock, S., Chakraborti, P., Ferguson, C., Gale, J., Gray, E., Hingorani, M., Hoskin, P.J., Lester, J.F., Malik, Z.I., McKinna, F., McPhail, N., Money-Kyrle, J., O’Sullivan, J., Parikh, O., Protheroe, A., Robinson, A., Srihari, N.N., Thomas, C., Wagstaff, J., Wylie, J., Zarkar, A., Parmar, M.K.B., Sydes, M.R.
Yayımlandı N Engl J Med (2017)

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

Yazar: Clarke, N W, Ali, A, Ingleby, F C, Hoyle, A, Amos, C L, Attard, G, Brawley, C D, Calvert, J, Chowdhury, S, Cook, A, Cross, W, Dearnaley, D P, Douis, H, Gilbert, D, Gillessen, S, Jones, R J, Langley, R E, MacNair, A, Malik, Z, Mason, M D, Matheson, D, Millman, R, Parker, C C, Ritchie, A W S, Rush, H, Russell, J M, Brown, J, Beesley, S, Birtle, A, Capaldi, L, Gale, J, Gibbs, S, Lydon, A, Nikapota, A, Omlin, A, O'Sullivan, J M, Parikh, O, Protheroe, A, Rudman, S, Srihari, N N, Simms, M, Tanguay, J S, Tolan, S, Wagstaff, J, Wallace, J, Wylie, J, Zarkar, A, Sydes, M R, Parmar, M K B, James, N D
Yayımlandı Ann Oncol (2019)